Mental Fatigue Clinical Trial
— ALERMENOfficial title:
A Randomized, Double Dummy, Double Blind, Placebo Controlled Cross Over Study to Evaluate Efficacy of Investigational Product E-AG-01/ E-AG02/ E-AG-03/ E-AG-04 on Alertness and Mental Fatigue
The current study is design to asses the effect of E-AG-01/ E-AG-02/ E-AG-03 on mental alertness as compared to placebo.
Status | Completed |
Enrollment | 59 |
Est. completion date | August 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Healthy Male and female computer literate subjects (able to use computers/related technology efficiently)in the age group of 18-40 years of age. - Subject should be moderate caffeine consumers. - All subjects should be predominantly right handed. - Subject has a body mass index (BMI) of =18.5 and <25.00 kg/m2. - Subjects with Generalized Anxiety Disorder Screener (GAD-7) score = 7. - Subjects screened for depression by Patient Health Questionnaire-9 (PHQ-9) with score = 14. - Subjects having score of at least 50 ± 20 two out of three readings on Jin Fan's Attention Network Test (ANT) version 1.3.0 after 24 hrs of caffeine abstinence performed at an interval of 30-60 mins each. - Subject is willing to refrain from consuming caffeine and caffeine-containing products 24 hrs prior to enrollment and during the study prior to all visit to site. - Subject agrees to refrain from using turmeric, ginger, cardamom, lemon grass , galangal, beetle leave, and beetle nuts containing products like thai food, tea masala, thai sauces, mouth freshener, paan, etc on the day prior to clinic visit. - Subject is willing to refrain from vigorous physical activity 12 hrs prior to clinic visit. - Subject should complete at least 7-8 hours of sleep on the night prior the clinic visit. - Subject is a non-smoker. - Female subjects currently in their menstrual period can be included only after the last day of menstrual flow. - Female Subjects consuming oral contraceptives can be included in study after a washout period of 7 days and are willing to stop its use during the study and opt for barrier contraceptive method. - Subject understands the study procedures and signed informed consent form to participate in the study and authorization for release of relevant protected health information to the study Investigator. Exclusion Criteria: - Subjects unable to abstain from caffeine containing products for 24 hrs. - Subjects suffering from primary or secondary insomnia with/ without active treatment. - Subjects with Generalized Anxiety Disorder Screener (GAD-7) score > 7. - Subjects with Personal health Questionnaire Score > 14. - Subjects suffering from type II Diabetes Mellitus. - Subject having health conditions that would prevent him/her from fulfilling the study requirements as judged by the investigator on the basis of medical history and routine laboratory test results. - Subject has uncontrolled hypertension (systolic blood pressure =140 mm Hg or diastolic blood pressure =90 mm Hg) as defined by the average blood pressure measured at screening as well as randomization. - Subject has a history or presence of clinically significant cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorders that, in the judgment of the Investigator, would interfere with the subject's ability to provide informed consent, comply with the study protocol (which might confound the interpretation of the study results), or put the subject at undue risk. - Subject has a history, in the judgment of the investigator, of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study. - Subject has a history or presence of oncological disorders. - Pregnant/ planning to be pregnant during the study period, lactating, or women of childbearing potential who are unwilling to commit to the use of a medically approved form of contraception throughout the study period. - Use of any psychotropic medication within four weeks of screening and throughout the study. - Use of antibiotics or signs of active systemic infection. Treatment visits will be rescheduled to allow the subject to wash off of the antibiotic for at least five days prior to any test visit. - Subject has had exposure to any non-registered drug product within 30 days prior to the screening visit. - Use of any other dietary supplements or herbal products. - Recent history of (within 12 months of screening visit 1) or strong potential for alcohol or substance abuse. - Subject has a known allergy or sensitivity to herbal product(s). |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
India | Vedic Lifesciences | Mumbai | Maharastra |
Lead Sponsor | Collaborator |
---|---|
Vedic Lifesciences Pvt. Ltd. | Enovate Biolife Pvt Ltd |
India,
Brunyé TT, Mahoney CR, Lieberman HR, Taylor HA. Caffeine modulates attention network function. Brain Cogn. 2010 Mar;72(2):181-8. doi: 10.1016/j.bandc.2009.07.013. Epub 2009 Sep 5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Alertness | To assess the effect on mental alertness by Attention network test after ingestion of single dose of investigational product. | Five hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05559034 -
Brain Oxygenation Marker for Cognitive Function in Healthy Adults
|
||
Completed |
NCT03576391 -
The Influence of Fatigue on Trunk Motor Control and Brain Activity
|
N/A | |
Recruiting |
NCT06081439 -
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
|
||
Recruiting |
NCT05679882 -
Effects of Natural Sounds on Attention Restoration Outdoors
|
N/A | |
Active, not recruiting |
NCT01206829 -
Hearing Impairment, Cognitive Therapy and Coping
|
Phase 1 | |
Completed |
NCT03643406 -
The Effect of Mental Fatigue on Lower Limb Functional Performance Tests and Brain Activity in a Healthy Population
|
N/A | |
Completed |
NCT06028698 -
Effects of Music on Table Tennis Stroke Performance Among Mentally Fatigued University Players
|
N/A | |
Not yet recruiting |
NCT04576026 -
Exogenous Ketone Supplementation and Cognitive Function During Exercise
|
N/A | |
Recruiting |
NCT05678374 -
Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
|
||
Completed |
NCT06384586 -
Investigation of Dietary Supplement Liquid Shot Products on Mental Energy, Cognition (Acuity),and Mood
|
N/A | |
Completed |
NCT04954430 -
The Reliability Assessment of Emergency Paramedics' Fatigue Using Automated Pupillometry
|
||
Not yet recruiting |
NCT06434688 -
Body Awareness and Mental Fatigue in Neck Pain
|
||
Active, not recruiting |
NCT06239142 -
Understanding Mental Fatigue After Subarachnoid Hemorrhage
|
||
Completed |
NCT02807649 -
Effect of Ginko and Cistanche Against Fatigue Symptoms
|
N/A | |
Recruiting |
NCT05100667 -
A Potential Role for Oxygen in the Development of Mental Fatigue and the Subsequent Decline in Cognitive Performance
|
N/A | |
Not yet recruiting |
NCT05355493 -
The Effect of Mental Fatigue on the Cerebral Oxygenation During Endurance Exercise
|
N/A | |
Completed |
NCT04721392 -
Mental Fatigue and Industrial Work Performance
|
N/A | |
Completed |
NCT00144235 -
Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue
|
Phase 3 | |
Completed |
NCT04693481 -
Effects of Nature Exposure Intervention on Soccer Performance Among Mentally Fatigued University Players
|
N/A | |
Completed |
NCT05952362 -
The Effect of Smartphone Addiction and Mental Fatigue on Working Memory in University Students
|